(Q33593516)

28 July 2017

Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials (English)

1 reference

28 July 2017

Gram-negative bacteria

0 references

6

Matthew E Falagas

1 reference

28 July 2017

3

Petros I Rafailidis

1 reference

28 July 2017

George Samonis

1

1 reference

28 July 2017

Sofia Maraki

series ordinal

2

1 reference

28 July 2017

Anastasios Kapaskelis

series ordinal

4

1 reference

28 July 2017

Antonia C Kastoris

series ordinal

5

1 reference

28 July 2017

1 June 2010

1 reference

28 July 2017

10

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

28 July 2017

5

1 reference

28 July 2017

6

1 reference

28 July 2017

961-970

1 reference

Antibacterial resistance worldwide: causes, challenges and responses

28 July 2017

1 reference

Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients

21 January 2018

1 reference

Current control and treatment of multidrug-resistant Acinetobacter baumannii infections

21 January 2018

1 reference

Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium

21 January 2018

1 reference

Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review.

21 January 2018

1 reference

Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.

21 January 2018

1 reference

Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin.

21 January 2018

1 reference

Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections

21 January 2018

1 reference

Fosfomycin: use beyond urinary tract and gastrointestinal infections

21 January 2018

1 reference

In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin

21 January 2018

1 reference

Susceptibility of urinary tract bacteria to fosfomycin

21 January 2018

1 reference

In vitro activity of fosfomycin against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures.

21 January 2018

1 reference

Effectiveness of fosfomycin combined with other antimicrobial agents against multidrug-resistant Pseudomonas aeruginosa isolates using the efficacy time index assay

21 January 2018

1 reference

Genotypic diversity and antibiotic susceptibility of Acinetobacter baumannii isolates in a Bulgarian hospital

21 January 2018

1 reference

Nosocomial transmission of CTX-M-2 beta-lactamase-producing Acinetobacter baumannii in a neurosurgery ward

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FMB.10.47

1 reference

28 July 2017

1 reference